Waddell & Reed Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $300M | Buy |
|
|||||
|
2020
Q4 | $330M | Sell |
|
|||||
|
2020
Q3 | $474M | Sell |
|
|||||
|
2020
Q2 | $510M | Sell |
|
|||||
|
2020
Q1 | $491M | Sell |
|
|||||
|
2019
Q4 | $505M | Buy |
|
|||||
|
2019
Q3 | $379M | Buy |
|
|||||
|
2019
Q2 | $410M | Buy |
|
|||||
|
2019
Q1 | $386M | Sell |
|
|||||
|
2018
Q4 | $360M | Sell |
|
|||||
|
2018
Q3 | $426M | Sell |
|
|||||
|
2018
Q2 | $379M | Sell |
|
|||||
|
2018
Q1 | $385M | Sell |
|
|||||
|
2017
Q4 | $428M | Sell |
|
|||||
|
2017
Q3 | $547M | Sell |
|
|||||
|
2017
Q2 | $519M | Buy |
|
|||||
|
2017
Q1 | $397M | Sell |
|
|||||
|
2016
Q4 | $284M | Sell |
|
|||||
|
2016
Q3 | $352M | Sell |
|
|||||
|
2016
Q2 | $366M | Sell |
|
|||||
|
2016
Q1 | $363M | Sell |
|
|||||
|
2015
Q4 | $628M | Buy |
|
|||||
|
2015
Q3 | $516M | Buy |
|
|||||
|
2015
Q2 | $585M | Buy |
|
|||||
|
2015
Q1 | $498M | Buy |
|
|||||
|
2014
Q4 | $455M | Sell |
|
|||||
|
2014
Q3 | $431M | Buy |
|
|||||
|
2014
Q2 | $361M | Buy |
|
|||||
|
2014
Q1 | $255M | Buy |
|
|||||
|
2013
Q4 | $265M | Buy |
|
|||||
|
2013
Q3 | $241M | Buy |
|
|||||
|
2013
Q2 | $233M | Buy |
|